期刊文献+

小儿先天性心脏病合并肺动脉高压的药物治疗 被引量:2

Medical treatment for children with pulmonary hypertension associated with congenital heart diseases
下载PDF
导出
摘要 先天性心脏病的患儿常合并有肺动脉高压,对于病程的变化和手术及药物治疗方案产生很大的影响。目前随着药物学的发展,临床上逐渐采用了诸如一氧化氮、磷酸二酯酶抑制剂、前列腺素类药物和内皮素拮抗剂等药物,配合先天性心脏病手术,通过单独给药和联合给药的方式,针对术前和术后的肺动脉高压进行治疗,已经取得了良好的效果。文章对这些药物各自的特点和应用进行综述。 Patients with congenital heart disease are usually associated with pulmonary arterial hypertension which affects the natural history,surgical protocol and medical treatment of disease. With the development of new drugs,some such as nitric oxide,inhibitors of phosphodiesterase,prostaglandin and endothelin antagonists are widely used to treat pulmonary arterial hypertension developed before or after surgery,and have improved the outcome of surgery. This article reviews the functions and use of these drugs.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2008年第9期816-819,共4页 Journal of Clinical Pediatrics
关键词 先天性心脏病 肺动脉高压 药物治疗 congenital heart disease pulmonary arterial hypertension medical treatment
  • 相关文献

参考文献20

  • 1Badesch DB,Abman SH,Simonneau G,et al.Medical therapy for pulmonary arterial hypertension:updated ACCP evidence-based clinical practice guidelines [J]. Chest,2007,131 (6):1917- 1928.
  • 2徐卓明,苏肇伉,陈玲,史珍英,杨艳明,张忠德,张文竹.先天性心脏病合并肺动脉高压时肺组织病理与免疫组化研究[J].临床儿科杂志,2002,20(12):748-750. 被引量:3
  • 3Hoffman JI, Rudolph AM. The natural history of ventricular septal defects in infancy [J]. Am J Cardiol, 1965,16(5) :634-653.
  • 4Steele P,Fuster V,Cohen M,et al. Isolated atrial septal defect with pulmonary vascular obstructive disease:long-term follow-up and prediction of outcome after surgical correction [J]. Circulation, 1987,76 (5) : 1037-1042.
  • 5Day RW,Hawkins JA,Mc Gough EC,et ol. Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease [J]. Ann Thorac Surg,2000,69(6) : 1907-1912.
  • 6Stoeker C,Penny DJ,Brizard CP,et al. Intravenous sildenafil and inhaled nitric oxide:a randomised trial in infants after cardiac surgery [J]. Intensive Care Med ,2003,29( 11 ) : 1996-2003.
  • 7Lammers AE, Hislop AA,Flynn Y,et ol. Epoprostenol treatment in children with severe pulmonary hypertension [J]. Heart, 2007,93 (6) :739-743.
  • 8Ivy DD,Doran AK,Smith KJ,et al. Short-and long-term effects of inhaled therapy in children with pulmonary arterial hypertension [J]. J Am Coil Cardiol,2008,51 (2):161-169.
  • 9Hoeper MM, Schwarze M, Ehlerding S,et al. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost,a prostacyclin analogue [J]. N Engl J Med,2000,342(25) :1866- 1870.
  • 10Hallioglu O, Dilber E, Celiker A. Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease [J]. Am J Cardiol,2003,92(8) : 1007-1009.

二级参考文献9

  • 1Rabinovitsh M. Pathophysiology of pulmonary hyperten sion. In: Emmanouilides GC, Riemenscheider TA, Allen HD. eds. Moss and Adams: Heart disease in infants, children, and adolescents, including the fetus and youngadult. 5th ed. Maryland: Williams&Wilkines Co. 1995: 1659- 1695.
  • 2Forstermann U, Kleinert H, Gath I, et al. Expression and expressional control of nitric oxide synthase in various cell types. In: Ignarro L. ed. Nitric oxide: Biochemistry, molecular biology, and therapeutic implications. 1st ed. Academic Press, Inc. California, 1995: 171 - 186.
  • 3Barnes PJ, Liu SF. Regulation of pulmonary vascular tone. Pharmacol Rev, 1995, 47: 88- 120.
  • 4Frostell CG, Fratacci MD, Wain JC, et al. Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation, 1991,83: 2038 - 2047.
  • 5Hoffmann GM, Ross GA, Day SE , et al . Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med, 1997, 25: 352 - 359.
  • 6Kouyoumdjian C, Adnot S, Levane M, et al. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest, 1994, 94: 578-584.
  • 7Giaid A. Nitric oxide and endothelin-1 in pulmonary hypertension. Chest, 1998, 114: 208s- 212s.
  • 8Mason NA, Springall DR, Burke M, et al. High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension. J Pathol, 1998, 185: 313-318.
  • 9Hislop AA, Springall DR, Oliverira H, et al. Endothelial nitric oxide synthase in hypoxic newborn porcine pul monary vessels. Arch Dis Child, 1997, 77: F16- F22.

共引文献2

同被引文献12

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部